Detalhe da pesquisa
1.
Enzalutamide in metastatic prostate cancer before chemotherapy.
N Engl J Med
; 371(5): 424-33, 2014 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-24881730
2.
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders.
Sci Transl Med
; 16(730): eadf1691, 2024 Jan 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38232139
3.
Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
Pediatr Pulmonol
; 42(4): 307-13, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17352404
4.
Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.
Clin Genitourin Cancer
; 15(5): 610-617.e3, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28344102
5.
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 70(4): 675-683, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27006332